Pharming (PHAR) Share-based Compensation (2020 - 2023)
Historic Share-based Compensation for Pharming (PHAR) over the last 4 years, with Q2 2023 value amounting to $4.0 million.
- Pharming's Share-based Compensation changed N/A to $4.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was $8.0 million, marking a year-over-year change of. This contributed to the annual value of $1.9 million for FY2021, which is 7079.7% down from last year.
- Per Pharming's latest filing, its Share-based Compensation stood at $4.0 million for Q2 2023.
- In the past 5 years, Pharming's Share-based Compensation ranged from a high of $4.0 million in Q2 2023 and a low of -$3.7 million during Q3 2021
- Moreover, its 4-year median value for Share-based Compensation was $1.1 million (2022), whereas its average is $735318.6.
- Examining YoY changes over the last 5 years, Pharming's Share-based Compensation showed a top increase of 2788672.95% in 2021 and a maximum decrease of 54856.91% in 2021.
- Quarter analysis of 4 years shows Pharming's Share-based Compensation stood at $6821.1 in 2020, then soared by 27886.73% to $1.9 million in 2021, then plummeted by 43.95% to $1.1 million in 2022, then surged by 271.03% to $4.0 million in 2023.
- Its last three reported values are $4.0 million in Q2 2023, $1.1 million for Q4 2022, and $1.1 million during Q1 2022.